ACC 2018 Middle East Conference

ACC Latin America Conference

Advanced Heart Failure Symposium

2018 Canadian Cardiovascular Congress

39th Panhellenic Congress of Cardiology

May 3, 2018 — The U.S. Food and Drug Administration (FDA) has expanded the indication for the Medtronic In.Pact Admiral Paclitaxel-coated Percutaneous Transluminal Angioplasty Balloon Catheter to include lesions up to 360 mm in length. 

This device is indicated for percutaneous transluminal angioplasty, after appropriate vessel preparation, of de novo, restenotic, or in-stent restenotic lesions with lengths up to 360 mm in superficial femoral or popliteal arteries with reference vessel diameters of 4-7 mm.

May 2, 2018 — Conavi Medical Inc. has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Novasight Hybrid System. The system enables simultaneous imaging of coronary arteries with both intravascular ultrasound (IVUS) and optical coherence tomography (OCT).

Select adult patients born with a single functioning ventricle, and who have undergone a surgical operation called the ‘Fontan procedure’ during childhood, are being enrolled in a new global-first clinical trial. The trial, led by a multi-disciplinary team of heart and lung physicians, will examine the effects of a portable, non-invasive medical device never before tested on patients with this cardiac condition.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now